Piramal Enterprises Q3 Review - Scaling Down Wholesale Lending; Pharma Segment Stable: Motilal Oswal 
Pirmala Enterprise Ltd. logo (image: Company website)

Piramal Enterprises Q3 Review - Scaling Down Wholesale Lending; Pharma Segment Stable: Motilal Oswal 

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Motilal Oswal Report

Piramal Enterprises Ltd.’s consolidate profit after tax increased 19% YoY to Rs 8 billion.

The financial services segment was characterized by a run-down in the wholesale lending book, the rollout of the retail segment, and marginal asset quality deterioration.

The complex hospital generics business was volatile due to Covid-19 in Q3 FY21.

On the other hand, the contract development and manufacturing organization; led by a strong order book); India consumer business (led by increased demand for self-care and baby care products) has been steady.

Click on the attachment to read the full report:

Motilal Oswal Piramal Enterprises Q3FY21 Result Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.